Dyne Therapeutics, Inc. SEC filings DYN

Dyne Therapeutics, Inc. has 796 filings in SEC EDGAR's recent list, going back to Jul 23, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Dyne Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
4 Insider transaction Oct 22, 2026 Oct 20, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 29, 2026 Sep 29, 2026
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
4 Insider transaction Sep 8, 2026 Sep 4, 2026
4 Insider transaction Sep 8, 2026 Sep 4, 2026
4 Insider transaction Sep 8, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 4, 2026 —
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
144 Notice of proposed sale Aug 14, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
144 Notice of proposed sale Jul 27, 2026 —
424B5 Prospectus supplement Jul 22, 2026 —
8-K Current report
Material agreement, Other events
Jul 22, 2026 Jul 21, 2026
424B5 Prospectus supplement Jul 21, 2026 —
8-K Current report
Other events
Jul 20, 2026 Jul 20, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 26, 2026 Jun 25, 2026
4 Insider transaction Jun 26, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
4 Insider transaction Jun 23, 2026 Jun 22, 2026
3 Initial insider ownership Jun 23, 2026 Jun 22, 2026
8-K Current report
Officer or director change
Jun 22, 2026 Jun 22, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 17, 2026 —
8-K Current report
Material agreement, New debt
Jun 17, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
8-K Current report
Shareholder vote results
Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2026 Jun 3, 2026
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 22, 2026 May 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 14, 2026 May 13, 2026
4 Insider transaction May 14, 2026 May 13, 2026
4 Insider transaction May 14, 2026 May 13, 2026
4 Insider transaction May 14, 2026 May 13, 2026
144 Notice of proposed sale May 13, 2026 —
144 Notice of proposed sale May 13, 2026 —
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
4 Insider transaction May 6, 2026 May 4, 2026
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 6, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
144 Notice of proposed sale Apr 28, 2026 —
144 Notice of proposed sale Apr 28, 2026 —
144 Notice of proposed sale Apr 28, 2026 —
144 Notice of proposed sale Apr 28, 2026 —
4 Insider transaction Apr 27, 2026 Apr 23, 2026
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 24, 2026 —
144 Notice of proposed sale Apr 24, 2026 —
144 Notice of proposed sale Apr 24, 2026 —
144 Notice of proposed sale Apr 24, 2026 —
144 Notice of proposed sale Apr 23, 2026 —
144 Notice of proposed sale Apr 23, 2026 —
144 Notice of proposed sale Apr 23, 2026 —
144 Notice of proposed sale Apr 23, 2026 —
4 Insider transaction Apr 23, 2026 Apr 21, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Apr 22, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 21, 2026 —
144 Notice of proposed sale Apr 21, 2026 —
144 Notice of proposed sale Apr 21, 2026 —
144 Notice of proposed sale Apr 21, 2026 —
4 Insider transaction Apr 21, 2026 Apr 17, 2026
144 Notice of proposed sale Apr 20, 2026 —
144 Notice of proposed sale Apr 20, 2026 —
144 Notice of proposed sale Apr 20, 2026 —
144 Notice of proposed sale Apr 20, 2026 —
4 Insider transaction Apr 17, 2026 Apr 15, 2026
PRE 14A Preliminary proxy statement Apr 9, 2026 Apr 9, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
144 Notice of proposed sale Apr 1, 2026 —
S-8 Employee stock plan registration Mar 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 10, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 9, 2026 —
4 Insider transaction Mar 6, 2026 Mar 5, 2026
4 Insider transaction Mar 6, 2026 Mar 5, 2026
4 Insider transaction Mar 6, 2026 Mar 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 6, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
S-8 Employee stock plan registration Mar 2, 2026 —
8-K Current report
Results of operations
Mar 2, 2026 Mar 2, 2026
10-K Annual report Mar 2, 2026 Dec 31, 2025
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 8, 2026 —
4 Insider transaction Dec 23, 2025 Dec 22, 2025
3 Initial insider ownership Dec 23, 2025 Dec 22, 2025
8-K Current report
Officer or director change
Dec 23, 2025 Dec 22, 2025
424B5 Prospectus supplement Dec 10, 2025 —
8-K Current report
Material agreement, Other events
Dec 10, 2025 Dec 9, 2025
424B5 Prospectus supplement Dec 8, 2025 —
8-K Current report
New debt
Dec 8, 2025 Dec 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 5, 2025 —
144 Notice of proposed sale Dec 5, 2025 —
4 Insider transaction Dec 5, 2025 Dec 5, 2025
4 Insider transaction Dec 5, 2025 Dec 5, 2025
4 Insider transaction Dec 5, 2025 Dec 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Oct 1, 2025
3 Initial insider ownership Oct 2, 2025 Oct 1, 2025
8-K Current report
Officer or director change
Oct 2, 2025 Oct 1, 2025
4 Insider transaction Sep 9, 2025 Sep 5, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
DYN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Large accelerated filer
SEC CIK
1818794

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.